Literature DB >> 8208655

Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium.

N Varma, G N Kerrigan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8208655      PMCID: PMC2399846          DOI: 10.1136/pgmj.69.812.497-a

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside.

Authors:  U Pedersen-Bjergaard; J Myhre
Journal:  BMJ       Date:  1991-02-02

2.  Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Authors:  S H Ralston; S J Gallacher; U Patel; F J Dryburgh; W D Fraser; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

3.  Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate.

Authors:  D I Jodrell; T J Iveson; I E Smith
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

4.  Acute intravenous infusion of disodium dihydrogen (1-hydroxyethylidene)diphosphonate: mechanism of toxicity.

Authors:  M D Francis; C L Slough
Journal:  J Pharm Sci       Date:  1984-08       Impact factor: 3.534

5.  Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

Authors:  D E Hughes; B R MacDonald; R G Russell; M Gowen
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

  5 in total
  2 in total

Review 1.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

2.  Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.

Authors:  A Mishra; L Wong; J Jonklaas
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.